Karyopharm Therapeutics I... (KPTI)

NASDAQ: KPTI · Real-Time Price · USD

6.39

0.32 (5.27%)

At close: Apr 29, 2025, 3:59 PM

6.04

-5.48%

After-hours: Apr 29, 2025, 05:54 PM EDT

Karyopharm Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	145.24M	146.03M	157.07M	209.82M	108.08M	40.89M	30.34M	1.6M	154K
Cost of Revenue	6.01M	4.94M	5.21M	3.4M	2.71M	2.41M	161.37M	107.27M	86.94M
Gross Profit	139.23M	141.09M	151.86M	206.42M	105.38M	38.49M	-131.04M	-105.67M	-86.78M
Operating Income	-119.44M	-129.54M	-142.2M	-98.27M	-171.85M	-189.28M	-179.88M	-130.54M	-110.73M
Interest Income	7.4M	10.94M	2.36M	582K	2.82M	5.42M	4.03M	1.7M	1.28M
Pretax Income	-76.36M	-142.78M	-164.92M	-123.82M	-195.96M	-199.55M	-178.38M	-128.92M	-109.44M
Net Income	-76.42M	-143.1M	-165.29M	-124.09M	-196.27M	-199.59M	-178.41M	-128.98M	-109.58M
Selling & General & Admin	115.44M	131.88M	145.4M	143.85M	126.42M	105.42M	48.85M	24.87M	23.95M
Research & Development	143.23M	138.75M	148.66M	160.84M	150.81M	122.34M	161.37M	107.27M	86.94M
Other Expenses	n/a	n/a	-83K	-85K	206K	-50K	-33K	-81K	10K
Operating Expenses	258.67M	270.63M	294.06M	304.69M	277.23M	227.76M	210.22M	132.14M	110.89M
Interest Expense	37.42M	23.82M	25M	26.05M	27.14M	15.65M	2.49M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	264.68M	275.57M	299.28M	308.09M	279.94M	230.17M	210.22M	132.14M	110.89M
Income Tax Expense	57K	323K	369K	268K	309K	40K	26K	63K	139K
Shares Outstanding (Basic)	121.86M	114.22M	81.87M	75.22M	72.04M	61.96M	56.78M	45.9M	37.52M
Shares Outstanding (Diluted)	126.81M	114.22M	81.87M	75.22M	72.04M	61.96M	56.78M	45.9M	37.52M
EPS (Basic)	-0.63	-1.25	-2.02	-1.65	-2.72	-3.22	-3.14	-2.81	-2.92
EPS (Diluted)	-0.6	-1.25	-2.02	-1.65	-2.72	-3.22	-3.14	-2.81	-2.92
EBITDA	-38.6M	-118.42M	-139.31M	-96.98M	-167.85M	-182.93M	-175.15M	-128.21M	-108.72M
EBIT	-38.94M	-118.95M	-139.93M	-97.77M	-168.82M	-183.9M	-175.89M	-128.92M	-109.44M
Depreciation & Amortization	340K	530K	621K	789K	972K	974K	735K	713K	717K